Inflammatory Cell Recruitment in Cardiovascular Disease

Area of Science:

• Cardiovascular Biology
• Immunology
• Translational Medicine

Background:

• Atherosclerosis is a chronic inflammatory disease of arteries, driven by leukocyte infiltration into the subendothelial space.
• Leukocyte accumulation exacerbates atherosclerosis, its complications (myocardial infarction, stroke), and impacts cardiac healing post-infarction.
• Inflammation involves systemic and local mediators, alongside tissue-specific molecules regulating leukocyte homing, adhesion, and transmigration.

Purpose of the Study:

• To detail receptor-ligand pairs governing leukocyte accumulation in atherosclerotic plaques and infarcted myocardium.
• To identify challenges in translating anti-leukocyte therapies into clinical practice.
• To discuss potential future medical therapies targeting leukocyte accumulation.

Main Methods:

• Review of experimental studies, primarily in mouse models, to understand leukocyte accumulation mechanisms.
• Analysis of known soluble mediators and tissue-specific molecules involved in leukocyte trafficking.
• Examination of clinical validation of anti-leukocyte therapies in humans.

Main Results:

• Numerous receptor-ligand pairs are identified that direct leukocyte entry into atherosclerotic plaques and damaged heart tissue.
• Current anti-leukocyte therapies face challenges due to lack of tissue-specificity and unspecific inhibition strategies.
• Mouse models have advanced conceptual understanding, but human translation remains limited.

Conclusions:

• Understanding specific leukocyte-guiding molecules is crucial for developing effective atherosclerosis and myocardial infarction therapies.
• Future therapies should focus on precise targeting of leukocyte interactions to overcome current clinical translation barriers.
• Targeting receptor-ligand pairs offers a promising avenue for modulating leukocyte accumulation in cardiovascular diseases.